Paolo Tarantino
Paolo Tarantino/X

Paolo Tarantino: Subsequent Treatments After Trastuzumab Deruxtecan in Patients with Metastatic Breast Cancer 

Paolo Tarantino, 2025 Yvonne’s “Top Voice” Award Winner, Research Fellow at Dana-Farber Cancer Institute, shared a post on LinkedIn about a recent article he and colleagues authored:

“Proud to see our Flatiron analysis of outcomes with post-T-DXd regimens highlighted on NEJM JWatch.”

Title: Outcomes of subsequent treatment regimens after trastuzumab deruxtecan in patients with metastatic breast cancer

Authors: Paolo Tarantino, Do Lee, Julia Foldi, Pamela R. Soulos, Cary P. Gross, Tess O’Meara, Thomas Grinda, Stefania Morganti, Adrienne G. Waks, Eric P. Winer, Nancy U. Lin, Ian E. Krop, Sara M. Tolaney, Sarah Sammons, Maryam Lustberg

Read the Full Article in Journal of the National Cancer Institute.

Paolo Tarantino

Title: Sequential Cytotoxic Payloads Against Metastatic Breast Cancer

Authors: William J. Gradishar, reviewing Tarantino P et al

Read the Full Article in NEJM Journal Watch.

Paolo Tarantino

More posts featuring Paolo Tarantino on OncoDaily.